Lactate Dehydrogenase (LDH) Inhibitors

Lactate dehydrogenase (LDH) inhibitors are a specialized class of compounds that target and inhibit the activity of the enzyme LDH which plays a crucial role in cellular energy metabolism By blocking LDH these inhibitors disrupt the conversion of lactate to pyruvate which is an essential step in glycolysis

LDH inhibitors have garnered significant attention in the fields of cancer research and drug development as they have demonstrated potential in targeting cancer cells that rely heavily on glycolysis for energy production By inhibiting LDH these compounds disrupt the energy supply of cancer cells leading to impaired growth and increased vulnerability to other therapeutic interventions

Furthermore LDH inhibitors have shown promise in treating other diseases and conditions characterized by increased LDH activity such as heart disease and neurodegenerative disorders By modulating LDH activity these inhibitors offer a potential avenue for therapeutic intervention and disease management Our company specializes in providing a range of high-quality LDH inhibitors for research and drug discovery purposes

Catalog Number	Chemical Name	CAS #	Price
EI-0021	(±)-Gossypol	303-45-7	Online Inquiry
EI-1024	Galloflavin	568-80-9	Online Inquiry
EI-2040	Sodium Oxamate	565-73-1	Online Inquiry

Application

Lactate Dehydrogenase (LDH) inhibitors serve a crucial role in both research and medicine In the field of scientific investigation these inhibitors are commonly employed to study the function and activity of LDH enzymes in various biological processes By selectively blocking LDH activity researchers can gain a deeper understanding of its role in cellular metabolism and disease development potentially leading to the identification of novel therapeutic targets

In the medical realm LDH inhibitors have shown promise as a potential treatment for certain types of cancers LDH is often overexpressed in cancer cells and plays a critical role in their energy metabolism By inhibiting LDH activity these inhibitors can disrupt the cancer cells' ability to produce energy which may slow down their growth or even induce their death This presents a promising avenue for the development of targeted therapies against cancer

Furthermore LDH inhibitors have demonstrated potential in the treatment of other diseases such as ischemic stroke and heart failure In these conditions LDH levels are elevated leading to tissue damage and impaired cardiac function By inhibiting LDH activity these inhibitors have the potential to mitigate the harmful effects of excessive LDH production offering a path for the development of therapeutic interventions

In summary the applications of LDH inhibitors extend beyond research and hold promise in the realm of medicine for the treatment of cancer and various other diseases By selectively targeting LDH these inhibitors offer the potential to pave the way for novel treatments and therapies that can improve patient outcomes

Please note that all services are for research use only. Not intended for any clinical use.

Lactate Dehydrogenase (LDH) Inhibitors